WorldPing'Breakthrough' mRNA cancer drug curbs melanoma in large trial
US drugmakers Merck and Moderna said Wednesday a personalised cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough.
Brief by WorldPing · Original reporting by France 24
WorldPing
